Do DHCR7 genetic variants lower serum 25-hydroxyvitamin D by reducing 7-dehydrocholesterol availability?

The 7-dehydrocholesterol reductase (DHCR7) gene encodes the enzyme responsible for converting 7-dehydrocholesterol (7-DHC) to cholesterol, serving as a critical metabolic gatekeeper that regulates the systemic availability of vitamin D3 precursors in the skin.

Mechanistic pathway

• Substrate competition: DHCR7 directly competes with the non-enzymatic, photolytic conversion of 7-DHC to previtamin D3.
• Genetic variation: Genetic variants in the DHCR7 locus (specifically the rs12785878 risk allele) alter the expression or functional activity of the DHCR7 enzyme.
• Precursor depletion: Increased activity or expression of DHCR7 accelerates the enzymatic shunt of 7-DHC into the cholesterol pathway. This depletion of the cutaneous 7-DHC substrate leaves less precursor available in keratinocytes to absorb UVB radiation (wavelengths 290–315 nm) and undergo thermal isomerization into vitamin D3.
• Circulating levels: Because cutaneous synthesis is a major source of vitamin D, this substrate reduction directly limits the amount of vitamin D3 traveling to the liver for 25-hydroxylation, resulting in lower circulating levels of serum 25-hydroxyvitamin D [25(OH)D].

Clinical and age-related considerations

• Genome-wide association studies: Large-scale genetic analyses (e.g., sample sizes exceeding 400,000 individuals) show that DHCR7 risk alleles are among the strongest genetic determinants of vitamin D deficiency, associated with a significant decrease in serum 25(OH)D concentrations (typically a 1.5 to 2.5 nmol/L reduction per risk allele).
• Compounding age factors: In an older adult (e.g., 68 years of age), the epidermal concentration of 7-DHC is naturally reduced by up to 50% to 75% compared to younger individuals. The presence of DHCR7 variants further compounding this age-related decline significantly increases the risk of clinical vitamin D deficiency.

Bottom line

• DHCR7 genetic variants lower serum 25-hydroxyvitamin D levels by accelerating the enzymatic conversion of 7-dehydrocholesterol to cholesterol, thereby starving the skin of the critical precursor needed for UVB-driven vitamin D3 synthesis. Older adults are particularly vulnerable to this genetic effect due to a natural, age-related decline in epidermal 7-dehydrocholesterol levels.